U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Tuesday The Dow traded up 0.21% to 34,166.89 while the NASDAQ rose 1.09% to 13,666.65. The S&P ...

Neuropsychiatry-Focused Alto Neuroscience's Mid-Stage Depression Trial Disappoints, Analyst Notes Failure Raises Concerns About Platform Alto Neuroscience's ALTO-100 Phase 2b study for major ...

Beyond that, though Guggenheim forecasts ... Palo Alto Networks seesaw, Guggenheim Securities says. Analysts John DiFucci and Lawrence Vensko downgraded shares of the cybersecurity stock to ...

Alto Ingredients, Inc. engages in the production and marketing of specialty alcohols and essential ingredients. It operates through the following segments: Marketing and Distribution, Pekin ...